Disclosures for "A Case Report of Calcitonin Gene-Related Peptide Antagonist as Treatment for Nummular Headache"
-
Ms. Bashir has nothing to disclose.
-
Mrs. Carnes has nothing to disclose.
-
Dr. Hull has nothing to disclose.
-
Dr. Kanaan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Kanaan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven.